Scientific Program

Jointly organized by Taiwan Society of Nephrology and APSN AKI Committee

Venue: NTUH International Convention Center, Taipei, Taiwan

議程 (點我下載)
 

November 22, 2019 (Fri)                                                                                               101 Meeting Room
 

Time  Topic
 13:30-17:00  Oral Communication
 17:30-18:00  Cocktail Reception
 18:00-18:05  Opening Remark
 Kuo-Cheng Lu, MD, PhD.
 President, Taiwan Society of Nephrology
 Jin-Shuen Chen, MD, PhD.
 Secretary General, Taiwan Society of Nephrology
 18:05-18:35  Keynote Lecture: Integrated Kidney Care – A Global Perspective
 Philip Li, MD.
 Honorary Professor of Medicine, Chief of Nephrology and Consultant,
 Prince  of Wales Hospital, Chinese University of Hong Kong, Hong Kong
 18:35-19:00  From the Integrated Care of CKD Patients to the Status of HCV Infection
 in CKD/ ESRD Patients in Taiwan

 Shang-Jyh Hwang, MD, PhD.
 Professor of Medicine, Division of Nephrology, Kaohsiung Medical
 University Hospital,  Taiwan
 19:00-19:30  Campaign for HCV Eradication in ESRD Patients in Taiwan
 Ming-Lung Yu, MD, PhD.
 Vice President, Professor of Medicine, Kaohsiung Medical University;
 Division of Hepatology, Department of Medicine, Kaohsiung Medical
 University Hospital, Taiwan
 19:30-19:40  Q&A
 19:40-21:00  Welcome Party


November 23, 2019 (Sat)                                                                                               201 Meeting Room
 
Time  Topic
 09:00-09:05   Welcome Speech
 Kuo-Cheng Lu, MD, PhD.
 President, Taiwan Society of Nephrology
 09:05-09:10   Opening Remark
 Masaomi Nangaku, MD, PhD.
 President, Asian Pacific Society of Nephrology; Professor and Head of the
 Division of Nephrology and Endocrinology, Vice President of the University
 of Tokyo Hospital, Japan
 Symposium I. AKI to CKD
 Chairs: Masaomi Nangaku, Kuo-Cheng Lu
 09:10-09:30   1. Leptospirosis Kidney Disease – A Model for Understanding AKI to
 CKD and CKDu

 Chih-Wei Yang, MD.
 Professor of Medicine, Department of Nephrology, Linkou Chang Gung
 Memorial Hospital; Dean, College of Medicine, Chang Gung University,
 Taiwan
 09:30-09:50   2. Mechanisms of AKI to CKD Transition
 Motoko Yanagita, MD, PhD.
 Professor and Chair, Department of Nephrology, Kyoto University Graduate
 School of Medicine, Japan
 09:50-10:10   3. The role of Macrophages in AKI to CKD Transition
 Sang Kyung Jo, MD, PhD.
 Professor, Department of Internal Medicine, Korea University Medical
 College, Korea
 10:10-10:20  Q&A
 10:20-10:40  Coffee Break 
 Chairs: Philip Li, Zoltan Endre
 10:40-11:00   4. AKI-AKD-CKD Continuum – Chance to Intervene?
 Mai-Szu Wu, MD.
 Superintendent, Taipei Medical University Shuang Ho Hospital;
 Professor, Department of Internal Medicine, College of Medicine Taipei
 Medical University, Taiwan
 11:00-11:20   5. Post-AKI: Follow-up, Care, and Outcomes
 Shuei-Liong Lin, MD, PhD.
 Professor, Graduate Institute of Physiology, National Taiwan University
 College of Medicine, Taiwan
11:20-11:30  Q&A
 11:30-12:30  Expert Opinions I.
 Moderator: Masaomi Nangaku
 Panelists: Chih-Wei Yang, Kuo-Cheng Lu, Mai-Szu Wu, Motoko Yanagita,
 Philip Li, Sang Kyung Jo, Shuei-Liong Lin, Zoltan Endre
 Question 1: How to reduce AKI to CKD?
 Question 2: How to extend CKD care forward to AKI care?
 【Lunch Symposium】
 12:30-13:20  Chairs:林俊良                                                       Venue: 201 Meeting Room
 Why Convection Volume of Hemodiafiltration Matters?
 Professor Bernard Canaud
 Emeritus Professor, Montpellier University, School of Medicine, Montpellier

 *本節目由台灣費森尤斯醫藥股份有限公司贊助
 Chairs: 賴彬卿                                                      Venue: 203 Meeting Room
 Management of diabetic kidney disease: intraglomerular pressure
 matters and the beneficial effects of Aliskiren

 楊智超 醫師
 高雄長庚醫院 腎臟科

 *本節目由台灣李氏藥業有限公司贊助
 Chairs: 林裕峯                                                      Venue: 301 Meeting Room
 aTypical HUS: Where do we Stand in Taiwan
 吳麥斯 院長
 衛生福利部雙和醫院

 *本節目由台灣瑞頌有限公司贊助
 Chairs: 唐德成、邱怡文                                        Venue: 401 Meeting Room
 12:30-12:55
 Protein energy wasting: Global prevalence and outcome impact in CKD
 patients

 Angela Yee-Moon Wang, MD,phD.
 President of the International Society of Renal Nutrition and Metabolism, 
 Queen Mary Hospital, The University of Hong Kong, Hong Kong
 12:55-13:15
 Myth and Secrets of Low Protein Diet in CKD
 張智翔 醫師
 林口長庚紀念醫院 腎臟科

 *本節目由台灣費森尤斯卡比股份有限公司贊助
 Chairs: 田亞中、方德昭                                        Venue: 205 Meeting Room
 12:30-12:50
 Ferric Citrate for hyperphosphatemia treatment in end stage renal
 disease patients, and the post-marketing clinical experience in Taiwan

 李建德 副院長
 高雄長庚紀念醫院
 12:50-13:10
 Ferric Citrate for iron deficiency anemia management and prevention
 chronic kidney disease progressing

 唐德成 主任
 台北榮民總醫院 腎臟科

 *本節目由寶齡富錦生技股份有限公司贊助
 Symposium II. AKI on CKD
 Chairs: Kriengsak Vareesangthip, Jin-Shuen Chen
 13:30-13:50  6. Sub-clinical AKI and CKDu – One Disease or Two?
 Zoltan Endre, MD, PhD.
 Head of the Department of Nephrology, Prince of Wales Hospital;
 Professor of Medicine, University of New South Wales, Australia
 13:50-14:10   7. How AKI Affects CKD Progression
 Nattachai Srisawat, MD.
 Director, Excellence Center for Critical Care Nephrology, King
 Chulalongkorn Memorial Hospital, Thailand
 14:10-14:30  8. AKI on CKD – How Frequent is it?
 Vincent Wu, MD, PhD.
 Associate Professor, Department of Internal Medicine, National Taiwan
 University Hospital, Taiwan
 14:30-14:40   Q&A
 14:40-15:00  Coffee Break 
 Chairs: Yon Su Kim, Ying-Wei Wang
 15:00-15:20  9. Mechanisms of AKI-on-CKD
 Masaomi Nangaku, MD, PhD.
 President, Asian Pacific Society of Nephrology; Professor and Head of the
 Division of Nephrology and Endocrinology, Vice President of the University
 of Tokyo Hospital, Japan
 15:20-15:40  10. Intervening AKI on CKD
 Mark Okusa, MD.
 Professor of Medicine, Chief of Division of Nephrology, University of
 Virginia, U.S.A
 15:40-15:50  Q&A
 15:50-16:50  Expert Opinions II.
 Moderator: Philip Li
 Panelists: Jin-Shuen Chen, Kriengsak Vareesangthip, Mark Okusa, Masaomi
 Nangaku,  Nattachai Srisawat, Sunita Bavanandan, Vincent Wu, Ying-Wei Wang,
 Yon Su Kim, Zoltan Endre

 Question 3: How to recognize and manage AKI on CKD?
 Question 4: How to prevent AKI on CKD?
 16:50-17:10  Asia Pacific AKI to/on CKD Initiatives and Signing Ceremony
 Masaomi Nangaku, MD, PhD.
 President, Asian Pacific Society of Nephrology; Professor and Head of the   Division of Nephrology and Endocrinology, Vice President of the University
 of Tokyo Hospital, Japan
 17:10-17:20  Closing Remark
 Philip Li, MD.
 Honorary Professor of Medicine, Chief of Nephrology and Consultant,
 Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong
 17:20-17:25  Group Photo 


November 24, 2019 (Sun)                                                                                              201 Meeting Room
 
Time  Topic
 Chairs: 朱宗信                                           Special Lecture
 09:00-09:30  Frailty in CKD: an overview
 黃政文 醫師
 台大醫院 腎臟科
 International Symposium I       JSDT, KSN, TSN Joint Symposium
 09:30-09:40  Opening Remarks for Symposium
 Kuo-Cheng Lu, MD, PhD.
 President, Taiwan Society of Nephrology
 09:40-10:05  TSN-Quality of care for AKD
 Vin-Cent Wu, MD ,PhD
 National Taiwan University Hospital
 10:05-10:30  New era for AKI : Kidney Fibrosis after Acute Kidney Injury
 Jung Pyo Lee, MD
 Seoul National University College of Medicine, Boramae Medical Center
 10:30-10:55  JSDT-Can kidney biomarkers help timely interventions and
 prognostication
?
 Nobuhito Hirawa, MD
 Yokohama City University Medical Center
 10:55-11:20  TSN-Frontiers of acute dialysis
 Chih-Hsiang Chang, MD
 Chang Gung Memorial Hospital, Linkou Medical Center
 11:20-11:30  Closing Remarks and Q&A
 Chih-Jen Wu, MD ,PhD
 MacKay Memorial Hospital
 11:30-12:00            TSN General Assembly 台灣腎臟醫學會 會員大會
 【Lunch Symposium 】
 Chairs: 林水龍                                                                                  
 12:20-13:10  New Era of HD therapy – HDx
 Dr Chris McIntyre MBBS DM
 Professor of Medicine, Medical Biophysics and Pediatrics
 University of Western Ontario

 *本節目由百特醫療產品股份有限公司贊助
 【Home Dialysis】台灣基層透析協會主辦
 13:30-13:40  Opening Remarks For Symposium
 Meng-Ju Yang, MD
 楊孟儒 理事長

 台灣基層透析協會
 Chairs: 黃秋錦、曾國憲
 13:40-14:10  Current status and issues of home hemodialysis in Japan
 Haruki Wakai M.D.
 若井 陽希 醫師
 
President of Reiseikai Medical Corporation
 14:10-14:15  Q&A
 Chairs: 陳永昌、郭慧亮
 14:15-14:45  Patient esucation programs and rule construction between patients
 and medical staffs in home hemodialysis

 Satoshi Ebihara R.N., C.E, B.N.
 海老原 慧

 Registered Nurse, Clinical Engineer, Bachelor of Science, Reiseikai Medical
 Corporation Shinagawa Garden Clinic
 14:45-14:50  Q&A
 Chairs: 劉宏順、吳慶成
 14:50-15:20  Medical equipment, facility functions, and safety management in home
 hemodialysis

 Natsumi Abe C.E. M.T
 阿部 奈津美

 Clinical Engineer, Medical Technologist, Reiseikai Medical Corporation   Shinagawa Garden Clinic
 15:20-15:25  Q&A
 15:25-15:30  Closing Remarks For Symposium
 Hsin-Tai Lin, MD
 林新泰 秘書長
 台灣基層透析協會
 

November 24, 2019 (Sun)                                                                                              203 Meeting Room
 
Time  Topic
 【Lunch Symposium】
 Chairs: 彭渝森
 12:20-13:10  Management of tophaceous gout
 李克仁 醫師
 台大醫院 風濕科  

  *本節目由台灣安斯泰來製藥股份有限公司贊助
                                         【Nutrition            *本節目由台灣費森尤斯卡比股份有限公司贊助
 Chairs: 洪冠予、林堯彬
 13:30-14:00  Precision medicine for nutritional management of end stage kidney
 disease and transition to dialysis

 Angela Yee-Moon Wang, MD,phD.
 President of the International Society of Renal Nutrition and Metabolism, 
 Queen Mary Hospital, The University of Hong Kong, Hong Kong
 14:00-14:25  My gut feeling about PEW in CKD
 洪思群 主任
 台北慈濟醫院 內科部
 14:25-14:30  Q&A
 【Pediatric Nephrology】   
 Chairs: 林清淵
 15:00-15:30  先天性腎病症候群
 Congenital Nephrotic Syndrome
 錢建文 醫師
 彰化基督教兒童醫院 兒童腎臟科
 15:30-16:00  治療兒童腎病症候群只有類固醇嗎?
 Treatment the childhood idiopathic nephrotic syndrome: are steroids
 the answer?

 林清淵 醫師
 中國醫藥大學附設兒童醫院 兒童腎臟科
 16:00-16:30  兒童腎臟移植相關的特殊問題
 Special Issues in Pediatric Kidney Transplantation
 余美靜 醫師
 林口長庚紀念醫院 兒童腎臟科
 

November 24, 2019 (Sun)                                                                                                301 Meeting Room
 
Time  Topic
 10:00-11:00  TCDA General Assembly
【Lunch Symposium】    
 Chairs: 李柏蒼
 12:20-13:10  The role of Etelcalcetide in the management of CKD-MBD in
 hemodialysis patients

 Anjay Rastogi, MD. PhD.
 UCLA CORE Kidney Program Division of Nephrology
 Department of Medicine David Geffen School of Medicine UCLA

 *本節目由台灣安進藥品有限公司贊助
 International Symposium II         MSN, SNT, TSN Joint Symposium
 13:30-13:40   Opening Remarks for symposium
 Kuo-Cheng Lu, MD, PhD
 President, Taiwan Society of Nephrology
 13:40-14:10  What we have done for CKD management—Taiwan’s perspective
 Jer-Ming Chang, MD, PhD
 Nephrology, Kaohsiung Medical University
 14:10-14:40  Current Status of Nephrology in Malaysia
 Sunita Bavanandan, MD, PhD
 President, Malaysian Society of Nephrology
 14:40-15:10  Current Status of Nephrology in Thailand
 Kriengsak Vareesangthip, MD, PhD
 President, The Nephrology Society of Thailand
 15:10-15:30  Closing Remarks and Q&A
 Jer-Ming Chang, MD, PhD
 Nephrology, Kaohsiung Medical University
 【Ethics】 
 Chairs: 陳呈旭
 15:30-16:30  我們與生命自主的距離
 慢性腎臟病病人的預立醫療照護諮商—(ACP)及預立醫療決定(AD)
 朱為民 醫師
 台中榮民總醫院 職業醫學科


November 24, 2019 (Sun)                                                                                              401 Meeting Room
 
Time  Topic
 【Lunch Symposium】
 Chairs: 吳明儒
 12:20-13:10  Update management for Lupus Nephritis
 黃文男 主任            
 台中榮民總醫院 過敏免疫風濕科

 *本節目由台灣諾華股份有限公司贊助
 【Clinical Nephrology】 
 13:30-13:40  Opening Remarks for symposium
 Jin-Shuen Chen, MD, PhD
 Secretary General, Taiwan Society of Nephrology 
 Chairs: Chih-Jen Wu, Chia-Chao Wu
 13:40-14:10  Vascular Calcification in CKD-MBD patients
 Masaki Oya, MD, PhD
 Assistant Professor, Department of Nephrology
 Wakayama Medical University
 14:10-14:15  Q&A
 Chairs: Shang-Jyh Hwang, Yu-Wei Fang
 14:15-14:45  New Therapeutic Strategy for CKD-MBD
 Takashi Shigematsu MD.,PhD.
 Professor, Department of Nephrology
 Wakayama Medical University
 14:45-14:50  Q&A
 Chairs: Chih-Ching Lin, Jia-Xun Lin
 14:50-15:20  Uremic Vascular Biology: from Vascular Access to
 Cardiovascular
  Disease in CKD and ESKD
 Prabir Roy-Chaudhury MD, PhD, FRCP (Edin)
 University of North Carolina (UNC) Kidney Center
 15:20-15:25  Q&A
 15:25-15:30  Closing Remarks for symposium
 Jin-Shuen Chen, MD, PhD
 Secretary General, Taiwan Society of Nephrology
 【Educational Research】  
 Chairs: 方基存
 15:30-16:30  醫學教育進入精準學習:虛擬診療訓練
 蔡淳娟 教授
 高雄醫學大學醫學院

 

Supported by: Bureau of Foreign Trade